Cumberland Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cumberland Partners's AMGN Position: Q1 2024 in Review
Cumberland Partners sold out of Amgen (AMGN) in Q1 2024, closing a stake of 3,580 shares — an estimated $1.03M sold.
Cumberland Partners first reported a position in AMGN in Q4 2015 and held it in 20 quarters. The position peaked at $2.58M in Q4 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.
- Cumberland Partners reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
- Cumberland Partners sold 3,580 Amgen shares in Q1 2024, an estimated $1.03M.
- Cumberland Partners first reported a position in Amgen in Q4 2015 and held it in 20 quarters.
- Cumberland Partners's Amgen position peaked at $2.58M in Q4 2022.
- 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.
Based on Cumberland Partners's 13F filing for Q1 2024, filed 9 May 2024.